1. Home
  2. MNMD vs WGO Comparison

MNMD vs WGO Comparison

Compare MNMD & WGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mind Medicine (MindMed) Inc.

MNMD

Mind Medicine (MindMed) Inc.

HOLD

Current Price

$13.44

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo Winnebago Industries Inc.

WGO

Winnebago Industries Inc.

HOLD

Current Price

$40.89

Market Cap

1.1B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
MNMD
WGO
Founded
2019
1958
Country
United States
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Homebuilding
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MNMD
WGO
Price
$13.44
$40.89
Analyst Decision
Strong Buy
Buy
Analyst Count
9
12
Target Price
$30.33
$43.00
AVG Volume (30 Days)
2.0M
654.7K
Earning Date
11-06-2025
12-19-2025
Dividend Yield
N/A
3.35%
EPS Growth
N/A
N/A
EPS
N/A
1.29
Revenue
N/A
$2,875,300,000.00
Revenue This Year
N/A
$3.85
Revenue Next Year
N/A
$5.20
P/E Ratio
N/A
$32.56
Revenue Growth
N/A
1.38
52 Week Low
$4.70
$28.00
52 Week High
$14.43
$50.82

Technical Indicators

Market Signals
Indicator
MNMD
WGO
Relative Strength Index (RSI) 58.52 56.14
Support Level $12.70 $40.23
Resistance Level $14.28 $43.38
Average True Range (ATR) 0.70 1.96
MACD 0.10 0.03
Stochastic Oscillator 62.28 39.98

Price Performance

Historical Comparison
MNMD
WGO

About MNMD Mind Medicine (MindMed) Inc.

Mind Medicine Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. It is developing a pipeline of product candidates targeting neurotransmitter pathways that play key roles in brain health disorders. This includes explicitly pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, as its key product candidates. The MM120 is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that is being developed to treat generalized anxiety disorder and clinical depressive disorder, and the MM402 is a proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), being developed to treat autism spectrum disorder (ASD).

About WGO Winnebago Industries Inc.

Winnebago Industries manufactures Class A, B, and C motor homes along with towables, customized specialty vehicles, boats, and parts. Headquartered in Eden Prairie, Minnesota, Winnebago has been producing recreational vehicles since 1958. Revenue was nearly $3 billion in fiscal 2024. Winnebago expanded into towables in 2011 with the acquisition of SunnyBrook and acquired Grand Design in November 2016. Towables made up 83% of the firm's RV unit volume, up from 31% in fiscal 2016. The company's total RV unit volume was 38,796 in fiscal 2024. Winnebago expanded into boating in 2018 with the purchase of Chris-Craft, bought premium motor home maker Newmar in November 2019, and bought Barletta pontoon boats in August 2021. It also is developing electric and autonomous technology.

Share on Social Networks: